News
Terrible News for Pfizer Stock Investors
The past three years have been challenging for Pfizer (NYSE: PFE). Revenue and earnings have moved in the wrong direction, as has the company's share price. The stock is down by 56% since 2022
1 Thing Investors Must Know Before Buying the 52% Dip on UnitedHealth Group
UnitedHealth Group (NYSE: UNH) is central to the trillion-dollar U.S. healthcare industry. It's a behemoth that generates over $400 billion in annual revenue with insurance, pharmacy, care services
UnitedHealth Group Stock Is Near 5-Year Lows: Is It a Bargain Buy?
UnitedHealth Group (NYSE: UNH) is one of the biggest health insurers in the U.S. It plays a critical role in the healthcare industry, and for years, it has been a sound stock to invest in.
This
Is Pfizer Stock a Buy After This $1.25 Billion Investment?
Pfizer (NYSE: PFE) made a fortune thanks to its work in the COVID-19 market. In 2022, it became the first company in the biopharmaceutical industry to generate $100 billion in annual sales.
However
Down 63%, Should You Buy the Dip on Pfizer?
It's been a tough go for Pfizer (NYSE: PFE). Shares of the pharmaceutical giant are down over 60% from their highs, a multi-year slide since pandemic-related sales peaked a few years ago. But that's
1 Ultra-High-Yield Dividend Stock Down 57% to Buy Hand Over Fist
Most people like to buy products when prices are cheaper. That's why you'll probably see lots of car dealers, furniture stores, and retailers advertising special sales during the Memorial Day
Pfizer Stock Analysis: Buy, Sell, or Hold?
Pfizer's (NYSE: PFE) management team is confident in its 2025 opportunities.
*Stock prices used were the afternoon prices of May 20, 2025. The video was published on May 22, 2025.
Why Did UnitedHealth CEO Andrew Witty Resign?
These are the reasons that led to the resignation of UnitedHealth (NYSE: UNH) CEO Andrew Witty.
*Stock prices used were the afternoon prices of May 19, 2025. The video was published on May 21, 2025.
Why UnitedHealth Stock Sank Again Today
Shares of UnitedHealth Group (NYSE: UNH) plummeted again on Wednesday. The company's stock is down 5.8% as of market close, while the S&P 500 (SNPINDEX: ^GSPC) and the Nasdaq Composite (NASDAQINDEX:
Here's What You Need to Know Before Buying or Selling United Health Stock
UnitedHealth (NYSE: UNH) is capturing investors' attention because of the massive changes surrounding the company.
*Stock prices used were the afternoon prices of May 18, 2025. The video was
2 High-Yield Dividend Stocks to Buy Right Now
Though there are plenty of dividend stocks on the market, they aren't all created equal. Consider that the average dividend yield for the S&P 500 (SNPINDEX: ^GSPC) is 1.3%, which is not particularly
The Best Healthcare Stocks: UnitedHealth Stock vs. CVS Stock
UnitedHealth (NYSE: UNH) and CVS (NYSE: CVS) are facing headwinds in the healthcare industry that are unique and shared.
*Stock prices used were the afternoon prices of May 18, 2025. The video was
What's Going on With UnitedHealth Stock?
UnitedHealth (NYSE: UNH) stock is down considerably from its highs, and the company is facing several challenges simultaneously.
*Stock prices used were the afternoon prices of May 16, 2025. The
UnitedHealth Group Stock Just Hit a 5-Year Low. 5 Things Investors Need to Know.
Few stocks have been as resilient as UnitedHealth Group (NYSE: UNH). The company operates the largest health insurance business in the U.S. It runs the second biggest pharmacy benefits manager
Should You Buy UnitedHealth Group Stock Now?
In this video, I will talk about the recent updates regarding UnitedHealth Group (NYSE: UNH). Watch the short video to learn more, consider subscribing, and click the special offer link below.
Deckers Stock Is Among the Worst Performers in the S&P 500 in 2025. Should Investors Buy the Dip?
Shares of shoe company Deckers Outdoor (NYSE: DECK) are down about 37% in 2025, as of this writing, giving it the third worst performance for a constituent of the S&P 500. It only trails Moderna and
Massive News for UnitedHealth Stock Investors!
UnitedHealth (NYSE: UNH) is reportedly under criminal investigation, and in this video, I will discuss what that could mean for investors.
*Stock prices used were the afternoon prices of May 14
Why Is Everyone Talking About UnitedHealth Group Stock?
In this video, I will talk about UnitedHealth Group (NYSE: UNH) and explain why the stock has crashed 50% in the past month. Watch the short video to learn more, consider subscribing, and click the
Why Is UnitedHealth Stock Crashing, and Is It a Buying Opportunity?
UnitedHealth (NYSE: UNH) made several massive announcements during an investor update that crashed the stock price.
*Stock prices used were the afternoon prices of May 12, 2025. The video was
Why Is Everyone Talking About UnitedHealth Stock?
UnitedHealth (NYSE: UNH) is capturing headlines for all the wrong reasons.
*Stock prices used were the afternoon prices of May 13, 2025. The video was published on May 15, 2025.
So
Here's How Many Shares of Pfizer You Should Own to Make $10,000 in Annual Dividend Income
Looking for income? You might want to check out Pfizer (NYSE: PFE). This big drugmaker has been a favorite for income investors for years. However, its dividend is arguably more attractive than
UnitedHealth Is One of the Worst S&P 500 Stocks In 2025. Here's Why It's Having an Even Bigger Impact on the Dow Jones.
Healthcare insurance giant UnitedHealth Group (NYSE: UNH) has seen its stock go from a stable stalwart to a falling knife, seemingly overnight. The stock's price crashed 22.4% on April 17 in
Down 59%, Is UnitedHealth Group Stock a Buy on the Dip?
Over the past year, America's typically predictable health insurance industry has been exciting in ways that investors hardly appreciate. In a nutshell, healthcare expenses have been outpacing the
Why UnitedHealth Stock Is Imploding Today
Shares of UnitedHealth Group (NYSE: UNH) are falling on Thursday. The company's stock has plummeted 15% as of 11:33 a.m. ET but lost as much as 19.2% earlier in the day. The collapse comes as the
What Most-Favored-Nation Status Could Mean for Pharmaceutical Stocks
Recently, the Trump Administration signed an executive order to lower the prices Americans pay for prescription drugs. According to the administration, the U.S. funds roughly 75% of global


